Provides additional health insurance coverage for clinical trials for cancer treatment by adding phase I and II to the currently covered phase III and IV clinical trials.
| Sponsor: |
Schaaf, Rob (028) |
| Co-Sponsor: |
Holand, Roy (135) ... et al. |
| Proposed Effective Date: |
8/28/2004 |
| LR Number: |
3866L.01I |
| Last Action: |
02/05/2004 - Referred: Financial Services (H) |
| Bill String: |
HB 1222 |
| Next House Hearing: |
Hearing not scheduled |
| Calendar: |
Bill currently not on a House calendar |